NEXT GENERATION CRYOABLATION TECHNOLOGY
The ProSense™ system is an effective liquid nitrogen (LN2) cryoablation solution, capable of destroying tumors safely, quickly and painlessly, without the need for surgery.
HOW IT WORKS
IceCure’s unique ultra-slim probe freezes targeted tissue within minutes using advanced cryotherapy technology.
Guided by CT or ultrasound, the probe is inserted into the tumor and liquid nitrogen generates sub-zero temperatures to turn the tumor into an ice ball. A freeze-thaw-freeze cycle destroys the targeted tissue immediately and leaves adjacent healthy tissue undamaged. The necrotic debris is eventually absorbed by the body.
Each procedure is easily customized and controlled from the ProSense™ console.
Fastest procedure available•5-15 minutes when treating a fibroadenoma.
LN2 (liquid nitrogen) for maximum cooling and efficacy•Produces faster cooling rate and lower tissue temperature than other methods, generating a larger destructive ice ball area.
Ease of use•Touch-screen user interface
Clinically proven•Treating fibroadenomas successfully since clinical trials began in 2012
•Cooled site estimated pain
Cosmetically superior results•Minimally invasive
Immediate patient recovery•Directly from procedure to daily activities
High patient satisfaction•Potentially reducing patient discomfort and anxiety
The ProSense™ system is considered an optimal solution for treating breast cancer. Clinical studies conducted worldwide with results published in peer-reviewed medical journals demonstrate that cryoablation treatment enables shorter, simpler, and cost-effective procedures, with lower risk of infections and complications.
Additional support can be found in the recent American Society of Breast Surgeons (ASBS) guidelines announcement and from the promising early evaluation of the company’s extensive ICE3 clinical trial in the U.S. throughout the treatment.